Patients with depression often exhibit increased levels of interleukin-6 (IL-6), IL-1β, IL-10, tumour necrosis factor-α (TNF-α), CRP, and transforming growth factor-β (TGF-β), many of which are produced in response to cellular stress through inflammasome activation [51,60]. Here, IL6 is linked to depressive symptom measurement.